English

VIROPHARMA INC

EDGAR

VPHM Quarterly report (10-Q) · filed 2013-10-31

79 filing records in this dataset, filed from 1997-03-20 to 2013-10-31. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

60.2 million USD

2009-03-31 · USD

Exact inputs and evidence

Revenue: 60190000 USD Source

Operating margin

-99.95%

2009-03-31 · %

Exact inputs and evidence

Operating Income: -60157000 USD Source
Revenue: 60190000 USD Source

Operating cash flow

-9.2 million USD

2009-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -9197000 USD Source

Free cash flow

-9.95 million USD

2009-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -9197000 USD Source
Capital Expenditure: 757000 USD Source

Cash and cash equivalents: 206 million USD 2013-09-30 Source
Exact value

205586000 USD
Long-term debt including current maturities: 160 million USD 2012-09-30 Source
Exact value

159633000 USD
Shares outstanding: 65.9 million shares 2013-09-30 Source
Exact value

65863021 shares

Reported share-count change

-0.01% · -3.94 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

65866958 shares · 2012-09-30· Source
65863021 shares · 2013-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

242 million USD

2008-04-01 – 2009-03-31

Exact inputs and evidence

Revenue: 65437000 USD · 2008-04-01 – 2008-06-30 Source
Revenue: 65913000 USD · 2008-07-01 – 2008-09-30 Source
Revenue: 232307000 USD · 2008-01-01 – 2008-12-31 Source
Revenue: 182287000 USD · 2008-01-01 – 2008-09-30 Source
Revenue: 60190000 USD · 2009-01-01 – 2009-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-10-31.

Financial data available through: 2012-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2008-12-31
Operating income: 10 of 11 periods available· newest 2012-12-31
Net income: 3 of 11 periods available· newest 2011-12-31
Operating cash flow: 10 of 11 periods available· newest 2012-12-31
Capital expenditure: 5 of 11 periods available· newest 2012-12-31
Total assets: 10 of 11 periods available· newest 2012-12-31
Total liabilities: 10 of 11 periods available· newest 2012-12-31
Current assets: 10 of 11 periods available· newest 2012-12-31
Current liabilities: 10 of 11 periods available· newest 2012-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2012-12-31
Long-term debt including current maturities: Multiple units; comparison withheld· newest 2011-12-31
Shares outstanding: 2 of 11 periods available· newest 2012-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Operating cash flow
-74.8%

Prior period

USD 170.73 million

2011-01-01 – 2011-12-31
Current period

USD 43.02 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

43015000 − 170726000 = -127711000 USD

170726000 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
43015000 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · VIROPHARMA INC · 2012-12-31 VIROPHARMA INC (edgar:946840) Year-over-year change in Operating cash flow: -127711000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 43015000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#188208 Filing: 000104746913001835 Input fundies:OperatingCashFlow: 170726000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#184135 Filing: 000104746913001835
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-55.7%

Prior period

USD 3.01 million

2011-01-01 – 2011-12-31
Current period

USD 1.33 million

2012-01-01 – 2012-12-31

Exact inputs and evidence

1332000 − 3007000 = -1675000 USD

3007000 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source
1332000 USD · 2012-01-01 – 2012-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · VIROPHARMA INC · 2012-12-31 VIROPHARMA INC (edgar:946840) Year-over-year change in Capital expenditure: -1675000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1332000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#1526706 Filing: 000104746913001835 Input fundies:CapitalExpenditure: 3007000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#184567 Filing: 000104746913001835
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Net income.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

Revenue USD 232.31 million 100% of revenue
Operating costs Derived USD 153.65 million 66% of revenue
Operating income USD 78.66 million 34% of revenue
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow USD 91.44 million 39% of revenue
Capital expenditure USD 2.53 million 1.1% of revenue
Free cash flow Derived USD 88.91 million 38% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2002 Not shown: operating income or net income is not reported.
2003 Not shown: operating income or net income is not reported.
2004 Not shown: operating income or net income is not reported.
2005 Not shown: operating income or net income is not reported.
2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.
2008 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2002 2002-01-01 – 2002-12-31	5537000	54449000 Derived	-48912000	Unavailable	Unavailable	Unavailable	Source 2002-01-01 – 2002-12-31: 5537000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -48912000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -61733000 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	1612000	35578000 Derived	-33966000	Unavailable	Unavailable	Unavailable	Source 2003-01-01 – 2003-12-31: 1612000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -33966000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -34201000 USD Inspect Operating Cash Flow Open source
2004 2004-01-01 – 2004-12-31	22389000	34398000 Derived	-12009000	Unavailable	Unavailable	Unavailable	Source 2004-01-01 – 2004-12-31: 22389000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -12009000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -20211000 USD Inspect Operating Cash Flow Open source
2005 2005-01-01 – 2005-12-31	132417000	44272000 Derived	88145000	Unavailable	Unavailable	Unavailable	Source 2005-01-01 – 2005-12-31: 132417000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: 88145000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 71503000 USD Inspect Operating Cash Flow Open source
2006 2006-01-01 – 2006-12-31	167181000	68375000 Derived	98806000	Unavailable	Unavailable	Unavailable	Source 2006-01-01 – 2006-12-31: 167181000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: 98806000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 95016000 USD Inspect Operating Cash Flow Open source
2007 2007-01-01 – 2007-12-31	203770000	87974000 Derived	115796000	Unavailable	Unavailable	114001000 Derived	Source 2007-01-01 – 2007-12-31: 203770000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 115796000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: 122867000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 8866000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	232307000	153652000 Derived	78655000	Unavailable	Unavailable	88908000 Derived	Source 2008-01-01 – 2008-12-31: 232307000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: 78655000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: 91437000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 2529000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 232.3M 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Revenue	5537000	Revenue: 5537000 Open source
20032003-12-31	Revenue	1612000	Revenue: 1612000 Open source
20042004-12-31	Revenue	22389000	Revenue: 22389000 Open source
20052005-12-31	Revenue	132417000	Revenue: 132417000 Open source
20062006-12-31	Revenue	167181000	Revenue: 167181000 Open source
20072007-12-31	Revenue	203770000	Revenue: 203770000 Open source
20082008-12-31	Revenue	232307000	Revenue: 232307000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

14% 2008

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Year over year	No prior comparable period	Revenue: 5537000 Open source
20032003-12-31	Year over year	-70.9%	Revenue: 1612000 Open source Revenue: 5537000 Open source
20042004-12-31	Year over year	1,288.9%	Revenue: 22389000 Open source Revenue: 1612000 Open source
20052005-12-31	Year over year	491.4%	Revenue: 132417000 Open source Revenue: 22389000 Open source
20062006-12-31	Year over year	26.3%	Revenue: 167181000 Open source Revenue: 132417000 Open source
20072007-12-31	Year over year	21.9%	Revenue: 203770000 Open source Revenue: 167181000 Open source
20082008-12-31	Year over year	14%	Revenue: 232307000 Open source Revenue: 203770000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 33.9% 2008

Free cash flow margin 38.3% 2008

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Operating margin	-883.4%	Operating Income: -48912000 Open source Revenue: 5537000 Open source
20032003-12-31	Operating margin	-2,107.1%	Operating Income: -33966000 Open source Revenue: 1612000 Open source
20042004-12-31	Operating margin	-53.6%	Operating Income: -12009000 Open source Revenue: 22389000 Open source
20052005-12-31	Operating margin	66.6%	Operating Income: 88145000 Open source Revenue: 132417000 Open source
20062006-12-31	Operating margin	59.1%	Operating Income: 98806000 Open source Revenue: 167181000 Open source
20072007-12-31	Operating margin	56.8%	Operating Income: 115796000 Open source Revenue: 203770000 Open source
20082008-12-31	Operating margin	33.9%	Operating Income: 78655000 Open source Revenue: 232307000 Open source
2002-12-31	Net margin	Not reported	Revenue: 5537000 Open source
2003-12-31	Net margin	Not reported	Revenue: 1612000 Open source
2004-12-31	Net margin	Not reported	Revenue: 22389000 Open source
2005-12-31	Net margin	Not reported	Revenue: 132417000 Open source
2006-12-31	Net margin	Not reported	Revenue: 167181000 Open source
2007-12-31	Net margin	Not reported	Revenue: 203770000 Open source
2008-12-31	Net margin	Not reported	Revenue: 232307000 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 5537000 Open source Operating Cash Flow: -61733000 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 1612000 Open source Operating Cash Flow: -34201000 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 22389000 Open source Operating Cash Flow: -20211000 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 132417000 Open source Operating Cash Flow: 71503000 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 167181000 Open source Operating Cash Flow: 95016000 Open source
20072007-12-31	Free cash flow margin	55.9%	Revenue: 203770000 Open source Operating Cash Flow: 122867000 Open source Capital Expenditure: 8866000 Open source
20082008-12-31	Free cash flow margin	38.3%	Revenue: 232307000 Open source Operating Cash Flow: 91437000 Open source Capital Expenditure: 2529000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 91.4M 2008

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Operating cash flow	-61733000	Operating Cash Flow: -61733000 Open source
20032003-12-31	Operating cash flow	-34201000	Operating Cash Flow: -34201000 Open source
20042004-12-31	Operating cash flow	-20211000	Operating Cash Flow: -20211000 Open source
20052005-12-31	Operating cash flow	71503000	Operating Cash Flow: 71503000 Open source
20062006-12-31	Operating cash flow	95016000	Operating Cash Flow: 95016000 Open source
20072007-12-31	Operating cash flow	122867000	Operating Cash Flow: 122867000 Open source
20082008-12-31	Operating cash flow	91437000	Operating Cash Flow: 91437000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 88.9M 2008

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Free cash flow	Unavailable	Operating Cash Flow: -61733000 Open source
20032003-12-31	Free cash flow	Unavailable	Operating Cash Flow: -34201000 Open source
20042004-12-31	Free cash flow	Unavailable	Operating Cash Flow: -20211000 Open source
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: 71503000 Open source
20062006-12-31	Free cash flow	Unavailable	Operating Cash Flow: 95016000 Open source
20072007-12-31	Free cash flow	114001000	Operating Cash Flow: 122867000 Open source Capital Expenditure: 8866000 Open source
20082008-12-31	Free cash flow	88908000	Operating Cash Flow: 91437000 Open source Capital Expenditure: 2529000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

31% 2008

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Liabilities / assets	84%	Total Liabilities: 145719986 Open source Total Assets: 173530757 Open source
20032003-12-31	Liabilities / assets	105.6%	Total Liabilities: 140967000 Open source Total Assets: 133458000 Open source
20042004-12-31	Liabilities / assets	114.7%	Total Liabilities: 204498000 Open source Total Assets: 178360000 Open source
20052005-12-31	Liabilities / assets	24.9%	Total Liabilities: 108548000 Open source Total Assets: 435525000 Open source
20062006-12-31	Liabilities / assets	4.1%	Total Liabilities: 17795000 Open source Total Assets: 429694000 Open source
20072007-12-31	Liabilities / assets	36%	Total Liabilities: 279503000 Open source Total Assets: 776066000 Open source
20082008-12-31	Liabilities / assets	31%	Total Liabilities: 336795000 Open source Total Assets: 1086129000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

8.3× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Current assets / current liabilities	17.89×	Current Assets: 161818215 Open source Current Liabilities: 9046374 Open source
20032003-12-31	Current assets / current liabilities	11.15×	Current Assets: 124242000 Open source Current Liabilities: 11146000 Open source
20042004-12-31	Current assets / current liabilities	4.27×	Current Assets: 56032000 Open source Current Liabilities: 13114000 Open source
20052005-12-31	Current assets / current liabilities	2.54×	Current Assets: 274829000 Open source Current Liabilities: 108163000 Open source
20062006-12-31	Current assets / current liabilities	15.97×	Current Assets: 284238000 Open source Current Liabilities: 17795000 Open source
20072007-12-31	Current assets / current liabilities	21.95×	Current Assets: 622773000 Open source Current Liabilities: 28370000 Open source
20082008-12-31	Current assets / current liabilities	8.3×	Current Assets: 360880000 Open source Current Liabilities: 43467000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2002-01-01 – 2002-12-31	Unavailable Not reported for this period.	−USD 61.73 million Exact value Exact value: -61733000 USD 2002-01-01 – 2002-12-31: -61733000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIROPHARMA INC · 2002-12-31 VIROPHARMA INC (edgar:946840) Operating Cash Flow: -61733000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -61733000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/0001193125-05-049767.txt#8233 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	Unavailable Not reported for this period.	−USD 34.2 million Exact value Exact value: -34201000 USD 2003-01-01 – 2003-12-31: -34201000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIROPHARMA INC · 2003-12-31 VIROPHARMA INC (edgar:946840) Operating Cash Flow: -34201000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -34201000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/0001193125-06-044016.txt#9197 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	Unavailable Not reported for this period.	−USD 20.21 million Exact value Exact value: -20211000 USD 2004-01-01 – 2004-12-31: -20211000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIROPHARMA INC · 2004-12-31 VIROPHARMA INC (edgar:946840) Operating Cash Flow: -20211000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20211000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/0001193125-07-042410.txt#8650 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	Unavailable Not reported for this period.	USD 71.5 million Exact value Exact value: 71503000 USD 2005-01-01 – 2005-12-31: 71503000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIROPHARMA INC · 2005-12-31 VIROPHARMA INC (edgar:946840) Operating Cash Flow: 71503000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 71503000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/0001193125-08-041644.txt#8682 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	Unavailable Not reported for this period.	USD 95.02 million Exact value Exact value: 95016000 USD 2006-01-01 – 2006-12-31: 95016000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIROPHARMA INC · 2006-12-31 VIROPHARMA INC (edgar:946840) Operating Cash Flow: 95016000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 95016000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/0001193125-09-041907.txt#9018 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	Unavailable Not reported for this period.	USD 122.87 million Exact value Exact value: 122867000 USD 2007-01-01 – 2007-12-31: 122867000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIROPHARMA INC · 2007-12-31 VIROPHARMA INC (edgar:946840) Operating Cash Flow: 122867000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 122867000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/0001193125-10-039104.txt#8881 The citation records this snapshot. The page link may show a newer release later.	USD 8.87 million Exact value Exact value: 8866000 USD 2007-01-01 – 2007-12-31: 8866000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIROPHARMA INC · 2007-12-31 VIROPHARMA INC (edgar:946840) Capital Expenditure: 8866000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8866000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/0001193125-10-039104.txt#8942 The citation records this snapshot. The page link may show a newer release later.	USD 114 million Calculation and evidence 122867000 − 8866000 USD Exact free cash flow: 114001000 USD 2007-01-01 – 2007-12-31: 122867000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 8866000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIROPHARMA INC · 2007-12-31 VIROPHARMA INC (edgar:946840) Free cash flow: 114001000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 122867000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/0001193125-10-039104.txt#8881 Input fundies:CapitalExpenditure: 8866000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/0001193125-10-039104.txt#8942 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	Unavailable Not reported for this period.	USD 91.44 million Exact value Exact value: 91437000 USD 2008-01-01 – 2008-12-31: 91437000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIROPHARMA INC · 2008-12-31 VIROPHARMA INC (edgar:946840) Operating Cash Flow: 91437000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 91437000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/0001193125-11-045119.txt#9850 The citation records this snapshot. The page link may show a newer release later.	USD 2.53 million Exact value Exact value: 2529000 USD 2008-01-01 – 2008-12-31: 2529000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIROPHARMA INC · 2008-12-31 VIROPHARMA INC (edgar:946840) Capital Expenditure: 2529000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2529000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/0001193125-11-045119.txt#9925 The citation records this snapshot. The page link may show a newer release later.	USD 88.91 million Calculation and evidence 91437000 − 2529000 USD Exact free cash flow: 88908000 USD 2008-01-01 – 2008-12-31: 91437000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 2529000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIROPHARMA INC · 2008-12-31 VIROPHARMA INC (edgar:946840) Free cash flow: 88908000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 91437000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/0001193125-11-045119.txt#9850 Input fundies:CapitalExpenditure: 2529000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/0001193125-11-045119.txt#9925 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	Unavailable Not reported for this period.	USD 193.52 million Exact value Exact value: 193517000 USD 2010-01-01 – 2010-12-31: 193517000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIROPHARMA INC · 2010-12-31 VIROPHARMA INC (edgar:946840) Operating Cash Flow: 193517000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 193517000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#184351 Filing: 000104746913001835 The citation records this snapshot. The page link may show a newer release later.	USD 2.81 million Exact value Exact value: 2807000 USD 2010-01-01 – 2010-12-31: 2807000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIROPHARMA INC · 2010-12-31 VIROPHARMA INC (edgar:946840) Capital Expenditure: 2807000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2807000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#184741 Filing: 000104746913001835 The citation records this snapshot. The page link may show a newer release later.	USD 190.71 million Calculation and evidence 193517000 − 2807000 USD Exact free cash flow: 190710000 USD 2010-01-01 – 2010-12-31: 193517000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 2807000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIROPHARMA INC · 2010-12-31 VIROPHARMA INC (edgar:946840) Free cash flow: 190710000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 193517000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#184351 Filing: 000104746913001835 Input fundies:CapitalExpenditure: 2807000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#184741 Filing: 000104746913001835 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	Unavailable Not reported for this period.	USD 170.73 million Exact value Exact value: 170726000 USD 2011-01-01 – 2011-12-31: 170726000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIROPHARMA INC · 2011-12-31 VIROPHARMA INC (edgar:946840) Operating Cash Flow: 170726000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 170726000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#184135 Filing: 000104746913001835 The citation records this snapshot. The page link may show a newer release later.	USD 3.01 million Exact value Exact value: 3007000 USD 2011-01-01 – 2011-12-31: 3007000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIROPHARMA INC · 2011-12-31 VIROPHARMA INC (edgar:946840) Capital Expenditure: 3007000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3007000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#184567 Filing: 000104746913001835 The citation records this snapshot. The page link may show a newer release later.	USD 167.72 million Calculation and evidence 170726000 − 3007000 USD Exact free cash flow: 167719000 USD 2011-01-01 – 2011-12-31: 170726000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 3007000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIROPHARMA INC · 2011-12-31 VIROPHARMA INC (edgar:946840) Free cash flow: 167719000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 170726000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#184135 Filing: 000104746913001835 Input fundies:CapitalExpenditure: 3007000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#184567 Filing: 000104746913001835 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	Unavailable Not reported for this period.	USD 43.02 million Exact value Exact value: 43015000 USD 2012-01-01 – 2012-12-31: 43015000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VIROPHARMA INC · 2012-12-31 VIROPHARMA INC (edgar:946840) Operating Cash Flow: 43015000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 43015000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#188208 Filing: 000104746913001835 The citation records this snapshot. The page link may show a newer release later.	USD 1.33 million Exact value Exact value: 1332000 USD 2012-01-01 – 2012-12-31: 1332000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VIROPHARMA INC · 2012-12-31 VIROPHARMA INC (edgar:946840) Capital Expenditure: 1332000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1332000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#1526706 Filing: 000104746913001835 The citation records this snapshot. The page link may show a newer release later.	USD 41.68 million Calculation and evidence 43015000 − 1332000 USD Exact free cash flow: 41683000 USD 2012-01-01 – 2012-12-31: 43015000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 1332000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VIROPHARMA INC · 2012-12-31 VIROPHARMA INC (edgar:946840) Free cash flow: 41683000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T08:59:13Z Snapshot: 8d76f7c840f02c4e26b556ede00d9229e2a76ffb79f04b7a110768c45464ffa4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/946840?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 43015000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#188208 Filing: 000104746913001835 Input fundies:CapitalExpenditure: 1332000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946840/000104746913001835/vphm-20121231.xml#1526706 Filing: 000104746913001835 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

79 filings · 1,305 latest values · 1,305 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000946840, 946840, VPHM, edgar:946840

Also known as VIROPHARMA INC

VIROPHARMA INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Company performance

What changed year over year

Operating cash flow

Capital expenditure

Where revenue goes

2008 2008-01-01 – 2008-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation